Monoclonal antibody Zt/g4 targeting RON receptor tyrosine kinase enhances chemosensitivity of bladder cancer cells to Epirubicin by promoting G1/S arrest and apoptosis

Epirubicin (EPI) is one of the most used intravesical chemotherapy agents after transurethral resection to non-muscle invasive bladder tumors (NMIBC) to prevent cancer recurrence and progression. However, even after resection of bladder tumors and intravesical chemotherapy, half of them will recur a...

全面介紹

Na minha lista:
書目詳細資料
發表在:Oncol Rep
Main Authors: Chen, Jun-Feng, Yu, Bi-Xia, Yu, Rui, Ma, Liang, Lv, Xiu-Yi, Cheng, Yue, Ma, Qi
格式: Artigo
語言:Inglês
出版: D.A. Spandidos 2017
主題:
Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5355669/
https://ncbi.nlm.nih.gov/pubmed/28075465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2017.5356
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍